• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过骨桥蛋白对羟磷灰石晶体成核和生长的抑制作用的动态光散射研究。

Dynamic light scattering study of inhibition of nucleation and growth of hydroxyapatite crystals by osteopontin.

机构信息

Department of Physics and Astronomy, University of Western Ontario, London, Ontario, Canada.

出版信息

PLoS One. 2013;8(2):e56764. doi: 10.1371/journal.pone.0056764. Epub 2013 Feb 14.

DOI:10.1371/journal.pone.0056764
PMID:23457612
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3572982/
Abstract

We study the effect of isoforms of osteopontin (OPN) on the nucleation and growth of crystals from a supersaturated solution of calcium and phosphate ions. Dynamic light scattering is used to monitor the size of the precipitating particles and to provide information about their concentration. At the ion concentrations studied, immediate precipitation was observed in control experiments with no osteopontin in the solution, and the size of the precipitating particles increased steadily with time. The precipitate was identified as hydroxyapatite by X-ray diffraction. Addition of native osteopontin (nOPN) extracted from rat bone caused a delay in the onset of precipitation and reduced the number of particles that formed, but the few particles that did form grew to a larger size than in the absence of the protein. Recombinant osteopontin (rOPN), which lacks phosphorylation, caused no delay in initial calcium phosphate precipitation but severely slowed crystal growth, suggesting that rOPN inhibits growth but not nucleation. rOPN treated with protein kinase CK2 to phosphorylate the molecule (p-rOPN) produced an effect similar to that of nOPN, but at higher protein concentrations and to a lesser extent. These results suggest that phosphorylations are critical to OPN's ability to inhibit nucleation, whereas the growth of the hydroxyapatite crystals is effectively controlled by the highly acidic OPN polypeptide. This work also demonstrates that dynamic light scattering can be a powerful tool for delineating the mechanism of protein modulation of mineral formation.

摘要

我们研究了骨桥蛋白(OPN)异构体对钙和磷酸盐离子过饱和溶液中晶体成核和生长的影响。动态光散射用于监测沉淀颗粒的大小,并提供有关其浓度的信息。在研究的离子浓度下,在没有骨桥蛋白的溶液中进行对照实验时,立即观察到沉淀,沉淀颗粒的大小随时间稳步增加。通过 X 射线衍射,将沉淀鉴定为羟基磷灰石。添加从大鼠骨骼中提取的天然骨桥蛋白(nOPN)会延迟沉淀的开始,并减少形成的颗粒数量,但形成的少数颗粒会生长到比没有蛋白质时更大的尺寸。缺乏磷酸化的重组骨桥蛋白(rOPN)不会延迟初始磷酸钙沉淀,但会严重减缓晶体生长,表明 rOPN 抑制生长而不抑制成核。用蛋白激酶 CK2 处理 rOPN 使其磷酸化(p-rOPN)产生类似于 nOPN 的效果,但在更高的蛋白质浓度下效果较小。这些结果表明,磷酸化对于 OPN 抑制成核的能力至关重要,而羟基磷灰石晶体的生长则受到高度酸性的 OPN 多肽的有效控制。这项工作还表明,动态光散射可以成为描绘蛋白质调节矿物质形成机制的有力工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/704d583fff22/pone.0056764.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/605fb7ccc59e/pone.0056764.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/abbb533356f2/pone.0056764.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/106db842c264/pone.0056764.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/127527e5086d/pone.0056764.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/26aa88b0342c/pone.0056764.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/8b4ffb58aa64/pone.0056764.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/fd79c158cbec/pone.0056764.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/44c15fa514d4/pone.0056764.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/6c0ada30b1b4/pone.0056764.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/704d583fff22/pone.0056764.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/605fb7ccc59e/pone.0056764.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/abbb533356f2/pone.0056764.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/106db842c264/pone.0056764.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/127527e5086d/pone.0056764.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/26aa88b0342c/pone.0056764.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/8b4ffb58aa64/pone.0056764.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/fd79c158cbec/pone.0056764.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/44c15fa514d4/pone.0056764.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/6c0ada30b1b4/pone.0056764.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0c8/3572982/704d583fff22/pone.0056764.g010.jpg

相似文献

1
Dynamic light scattering study of inhibition of nucleation and growth of hydroxyapatite crystals by osteopontin.通过骨桥蛋白对羟磷灰石晶体成核和生长的抑制作用的动态光散射研究。
PLoS One. 2013;8(2):e56764. doi: 10.1371/journal.pone.0056764. Epub 2013 Feb 14.
2
Role of phosphate groups in inhibition of calcium oxalate crystal growth by osteopontin.磷酸基团在骨桥蛋白抑制草酸钙晶体生长中的作用。
Cells Tissues Organs. 2009;189(1-4):44-50. doi: 10.1159/000151430. Epub 2008 Aug 15.
3
Role of osteopontin in modulation of hydroxyapatite formation.骨桥蛋白在羟基磷灰石形成中的调节作用。
Calcif Tissue Int. 2013 Oct;93(4):348-54. doi: 10.1007/s00223-013-9698-6. Epub 2013 Jan 19.
4
[Structural characteristics of osteopontin for calcium oxalate crystal].[草酸钙晶体的骨桥蛋白结构特征]
Nihon Hinyokika Gakkai Zasshi. 1999 Mar;90(3):436-44. doi: 10.5980/jpnjurol1989.90.436.
5
Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization.骨桥蛋白的磷酸化是抑制草酸钙结晶所必需的。
J Phys Chem B. 2008 Jul 31;112(30):9151-7. doi: 10.1021/jp804282u. Epub 2008 Jul 9.
6
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel.骨桥蛋白与羟基磷灰石的体外相互作用:在明胶凝胶中抑制羟基磷灰石的形成和生长
Bone Miner. 1993 Aug;22(2):147-59. doi: 10.1016/s0169-6009(08)80225-5.
7
Mineralization-inhibiting effects of transglutaminase-crosslinked polymeric osteopontin.转谷氨酰胺酶交联的聚骨桥蛋白的矿化抑制作用
Bone. 2017 Aug;101:37-48. doi: 10.1016/j.bone.2017.04.007. Epub 2017 Apr 18.
8
Effect of Phosphorylation on a Human-like Osteopontin Peptide.磷酸化对类人骨桥蛋白肽的影响。
Biophys J. 2017 Apr 25;112(8):1586-1596. doi: 10.1016/j.bpj.2017.03.005.
9
Kinetics of calcium oxalate crystal growth in the presence of osteopontin isoforms: an analysis by scanning confocal interference microcopy.骨桥蛋白亚型存在下草酸钙晶体生长的动力学:扫描共聚焦干涉显微镜分析
Calcif Tissue Int. 2009 Mar;84(3):240-8. doi: 10.1007/s00223-008-9215-5. Epub 2009 Feb 3.
10
Nucleation of hydroxyapatite by bone sialoprotein.骨唾液蛋白对羟基磷灰石的成核作用。
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8562-5. doi: 10.1073/pnas.90.18.8562.

引用本文的文献

1
Evidence for a possible quantum effect on the formation of lithium-doped amorphous calcium phosphate from solution.关于溶液中锂掺杂非晶态磷酸钙形成可能存在量子效应的证据。
Proc Natl Acad Sci U S A. 2025 Mar 11;122(10):e2423211122. doi: 10.1073/pnas.2423211122. Epub 2025 Mar 6.
2
Structure of biomimetic casein micelles: Critical tests of the hydrophobic colloid and multivalent-binding models using recombinant deuterated and phosphorylated β-casein.仿生酪蛋白胶束的结构:使用重组氘代和磷酸化β-酪蛋白对疏水胶体和多价结合模型的关键测试。
J Struct Biol X. 2024 Jan 22;9:100096. doi: 10.1016/j.yjsbx.2024.100096. eCollection 2024 Jun.
3

本文引用的文献

1
Matrix Gla protein inhibits ectopic calcification by a direct interaction with hydroxyapatite crystals.基质 Gla 蛋白通过与羟基磷灰石晶体的直接相互作用抑制异位钙化。
J Am Chem Soc. 2011 Nov 16;133(45):18406-12. doi: 10.1021/ja207628k. Epub 2011 Oct 24.
2
Phosphorylation of Ser136 is critical for potent bone sialoprotein-mediated nucleation of hydroxyapatite crystals.丝氨酸 136 的磷酸化对于骨涎蛋白介导的羟基磷灰石晶体成核至关重要。
Biochem J. 2010 May 27;428(3):385-95. doi: 10.1042/BJ20091864.
3
Roles of electrostatics and conformation in protein-crystal interactions.
Prenatal and Neonatal Bone Health: Updated Review on Early Identification of Newborns at High Risk for Osteopenia.
产前和新生儿骨骼健康:更新对骨质疏松症高危新生儿的早期识别综述。
Nutrients. 2023 Aug 9;15(16):3515. doi: 10.3390/nu15163515.
4
Matrix Vesicle-Mediated Mineralization and Osteocytic Regulation of Bone Mineralization.基质小泡介导的矿化与破骨细胞对骨矿化的调节。
Int J Mol Sci. 2022 Sep 1;23(17):9941. doi: 10.3390/ijms23179941.
5
Enzymatic Approach in Calcium Phosphate Biomineralization: A Contribution to Reconcile the Physicochemical with the Physiological View.酶法在磷酸钙生物矿化中的应用:在理化观点与生理观点之间寻求协调。
Int J Mol Sci. 2021 Nov 30;22(23):12957. doi: 10.3390/ijms222312957.
6
Binding Mode Characterization of Osteopontin on Hydroxyapatite by Solution NMR Spectroscopy.通过溶液 NMR 光谱法研究骨桥蛋白在羟基磷灰石上的结合模式。
Chembiochem. 2021 Jul 1;22(13):2300-2305. doi: 10.1002/cbic.202100139. Epub 2021 May 10.
7
Hyperphosphorylation of Human Osteopontin and Its Impact on Structural Dynamics and Molecular Recognition.人骨桥蛋白的过度磷酸化及其对结构动力学和分子识别的影响。
Biochemistry. 2021 May 4;60(17):1347-1355. doi: 10.1021/acs.biochem.1c00050. Epub 2021 Apr 20.
8
Osteopontin regulates biomimetic calcium phosphate crystallization from disordered mineral layers covering apatite crystallites.骨桥蛋白调节从覆盖在磷灰石晶体上的无定形矿层中仿生钙磷酸盐的结晶。
Sci Rep. 2020 Sep 24;10(1):15722. doi: 10.1038/s41598-020-72786-x.
9
Targeted Nanoparticle Binding to Hydroxyapatite in a High Serum Environment for Early Detection of Heart Disease.在高血清环境中靶向纳米颗粒与羟基磷灰石结合用于心脏病的早期检测
ACS Appl Nano Mater. 2018 Sep 28;1(9):4927-4939. doi: 10.1021/acsanm.8b01099. Epub 2018 Aug 21.
10
FGF adsorbed mesoporous bioactive glass with larger pores in enhancing bone tissue engineering.FGF 吸附大孔介孔生物活性玻璃在增强骨组织工程中的作用。
J Mater Sci Mater Med. 2019 Apr 13;30(4):48. doi: 10.1007/s10856-019-6252-8.
静电作用和构象在蛋白晶体相互作用中的作用。
PLoS One. 2010 Feb 19;5(2):e9330. doi: 10.1371/journal.pone.0009330.
4
Crystallization of calcium oxalates is controlled by molecular hydrophilicity and specific polyanion-crystal interactions.草酸钙的结晶受分子亲水性和特定的聚阴离子-晶体相互作用控制。
Langmuir. 2009 Oct 6;25(19):11635-46. doi: 10.1021/la901145d.
5
Phosphorylated proteins and control over apatite nucleation, crystal growth, and inhibition.磷酸化蛋白与对磷灰石成核、晶体生长及抑制的控制。
Chem Rev. 2008 Nov;108(11):4670-93. doi: 10.1021/cr0782729. Epub 2008 Oct 3.
6
Phosphorylation of osteopontin is required for inhibition of calcium oxalate crystallization.骨桥蛋白的磷酸化是抑制草酸钙结晶所必需的。
J Phys Chem B. 2008 Jul 31;112(30):9151-7. doi: 10.1021/jp804282u. Epub 2008 Jul 9.
7
Revisiting the method of cumulants for the analysis of dynamic light-scattering data.重新审视用于动态光散射数据分析的累积量方法。
Appl Opt. 2001 Aug 20;40(24):4087-91. doi: 10.1364/ao.40.004087.
8
Control of calcium oxalate crystal growth by face-specific adsorption of an osteopontin phosphopeptide.通过骨桥蛋白磷酸肽的面特异性吸附控制草酸钙晶体生长。
J Am Chem Soc. 2007 Dec 5;129(48):14946-51. doi: 10.1021/ja0745613. Epub 2007 Nov 10.
9
Mineralization kinetics: a constant composition approach.矿化动力学:恒组成方法。
Science. 1978 Jun 2;200(4345):1059-60. doi: 10.1126/science.200.4345.1059.
10
Inducers and inhibitors of biomineralization: lessons from pathological calcification.生物矿化的诱导剂和抑制剂:病理性钙化的经验教训。
Orthod Craniofac Res. 2005 Nov;8(4):229-31. doi: 10.1111/j.1601-6343.2005.00345.x.